Bayer Settles Roundup Lawsuit for Almost $11 Billion

Diversified German chemical and pharmaceutical company Bayer (OTC:BAYR.Y), has agreed to settle litigation over allegations that the weedkiller Roundup causes cancer in people exposed to it. The company, which inherited the product when it purchased chemical maker Monsanto in 2018, said resolution of the lawsuits will cost it between $10.1 billion and $10.9 billion, including addressing potential future litigation.